Vital Limited Logo

Vital Limited

VTL.NZ

(1.0)
Stock Price

0,31 NZD

-0.27% ROA

-0.59% ROE

0x PER

Market Cap.

11.218.046,00 NZD

164.44% DER

0% Yield

-0.27% NPM

Vital Limited Stock Analysis

Vital Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Vital Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.44x), the stock offers substantial upside potential at a bargain price.

2 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

3 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (2), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

4 ROE

The stock's ROE indicates a negative return (-60.18%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-25.79%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 DER

The stock is burdened with a heavy load of debt (184%), making it financially unstable and potentially risky for investors.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

Vital Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Vital Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Buy
4 Stoch RSI Sell

Vital Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Vital Limited Revenue
Year Revenue Growth
2004 17.100.273
2005 19.751.000 13.42%
2006 20.230.000 2.37%
2007 24.318.000 16.81%
2008 30.357.000 19.89%
2009 29.588.000 -2.6%
2010 29.451.000 -0.47%
2011 30.589.000 3.72%
2012 31.254.000 2.13%
2013 45.293.000 31%
2014 59.653.000 24.07%
2015 55.177.000 -8.11%
2016 56.291.000 1.98%
2017 34.047.000 -65.33%
2018 34.226.000 0.52%
2019 35.449.000 3.45%
2020 33.357.000 -6.27%
2021 35.239.000 5.34%
2022 31.456.000 -12.03%
2023 28.131.000 -11.82%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Vital Limited Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Vital Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 194.166
2005 409.000 52.53%
2006 397.000 -3.02%
2007 5.640.000 92.96%
2008 9.454.000 40.34%
2009 9.284.000 -1.83%
2010 10.564.000 12.12%
2011 10.997.000 3.94%
2012 9.630.000 -14.2%
2013 13.065.000 26.29%
2014 16.194.000 19.32%
2015 16.957.000 4.5%
2016 16.286.000 -4.12%
2017 11.388.000 -43.01%
2018 11.241.000 -1.31%
2019 12.072.000 6.88%
2020 11.994.000 -0.65%
2021 10.348.000 -15.91%
2022 11.435.000 9.51%
2023 10.938.000 -4.54%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Vital Limited EBITDA
Year EBITDA Growth
2004 7.567.587
2005 8.861.000 14.6%
2006 9.015.000 1.71%
2007 6.483.000 -39.06%
2008 8.222.000 21.15%
2009 8.143.000 -0.97%
2010 11.561.000 29.56%
2011 12.677.000 8.8%
2012 13.311.000 4.76%
2013 19.036.000 30.07%
2014 22.849.000 16.69%
2015 13.408.000 -70.41%
2016 12.963.000 -3.43%
2017 12.272.000 -5.63%
2018 12.441.000 1.36%
2019 11.201.000 -11.07%
2020 12.840.000 12.76%
2021 15.626.000 17.83%
2022 9.848.000 -58.67%
2023 9.887.000 0.39%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Vital Limited Gross Profit
Year Gross Profit Growth
2004 17.100.273
2005 19.751.000 13.42%
2006 20.230.000 2.37%
2007 13.570.000 -49.08%
2008 17.194.000 21.08%
2009 29.588.000 41.89%
2010 16.234.000 -82.26%
2011 17.824.000 8.92%
2012 17.099.000 -4.24%
2013 45.293.000 62.25%
2014 59.653.000 24.07%
2015 55.177.000 -8.11%
2016 56.291.000 1.98%
2017 34.047.000 -65.33%
2018 34.226.000 0.52%
2019 35.449.000 3.45%
2020 33.357.000 -6.27%
2021 35.239.000 5.34%
2022 31.456.000 -12.03%
2023 28.131.000 -11.82%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Vital Limited Net Profit
Year Net Profit Growth
2004 2.622.000
2005 3.029.000 13.44%
2006 3.114.000 2.73%
2007 3.632.000 14.26%
2008 3.698.000 1.78%
2009 3.825.000 3.32%
2010 3.859.000 0.88%
2011 4.804.000 19.67%
2012 5.405.000 11.12%
2013 3.597.000 -50.26%
2014 -8.348.000 143.09%
2015 1.344.000 721.13%
2016 -1.310.000 202.6%
2017 5.118.000 125.6%
2018 4.439.000 -15.3%
2019 4.054.000 -9.5%
2020 734.000 -452.32%
2021 841.000 12.72%
2022 -19.093.000 104.4%
2023 -183.000 -10333.33%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Vital Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Vital Limited Free Cashflow
Year Free Cashflow Growth
2004 -1.076.000
2005 -1.344.000 19.94%
2006 -2.844.000 52.74%
2007 -4.372.000 34.95%
2008 -6.356.000 31.21%
2009 -6.822.000 6.83%
2010 -6.357.000 -7.31%
2011 -5.097.000 -24.72%
2012 -4.225.000 -20.64%
2013 -5.081.000 16.85%
2014 -8.206.000 38.08%
2015 -6.182.000 -32.74%
2016 -5.697.000 -8.51%
2017 -2.983.000 -90.98%
2018 -6.602.000 54.82%
2019 -9.117.000 27.59%
2020 -7.950.000 -14.68%
2021 -9.268.000 14.22%
2022 -6.129.000 -51.22%
2023 -3.114.000 -96.82%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Vital Limited Operating Cashflow
Year Operating Cashflow Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Vital Limited Capital Expenditure
Year Capital Expenditure Growth
2004 1.076.000
2005 1.344.000 19.94%
2006 2.844.000 52.74%
2007 4.372.000 34.95%
2008 6.356.000 31.21%
2009 6.822.000 6.83%
2010 6.357.000 -7.31%
2011 5.097.000 -24.72%
2012 4.225.000 -20.64%
2013 5.081.000 16.85%
2014 8.206.000 38.08%
2015 6.182.000 -32.74%
2016 5.697.000 -8.51%
2017 2.983.000 -90.98%
2018 6.602.000 54.82%
2019 9.117.000 27.59%
2020 7.950.000 -14.68%
2021 9.268.000 14.22%
2022 6.129.000 -51.22%
2023 3.114.000 -96.82%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Vital Limited Equity
Year Equity Growth
2004 21.609.000
2005 21.038.000 -2.71%
2006 20.552.000 -2.36%
2007 21.938.000 6.32%
2008 22.254.000 1.42%
2009 22.858.000 2.64%
2010 24.581.000 7.01%
2011 26.903.000 8.63%
2012 28.393.000 5.25%
2013 39.521.000 28.16%
2014 25.741.000 -53.53%
2015 23.803.000 -8.14%
2016 20.209.000 -17.78%
2017 25.327.000 20.21%
2018 29.766.000 14.91%
2019 42.095.000 29.29%
2020 41.740.000 -0.85%
2021 41.783.000 0.1%
2022 21.667.000 -92.84%
2023 21.484.000 -0.85%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Vital Limited Assets
Year Assets Growth
2004 38.612.000
2005 34.154.000 -13.05%
2006 30.725.000 -11.16%
2007 56.745.000 45.85%
2008 59.331.000 4.36%
2009 58.011.000 -2.28%
2010 58.222.000 0.36%
2011 58.119.000 -0.18%
2012 58.275.000 0.27%
2013 92.902.000 37.27%
2014 79.444.000 -16.94%
2015 76.132.000 -4.35%
2016 70.624.000 -7.8%
2017 63.681.000 -10.9%
2018 64.135.000 0.71%
2019 67.486.000 4.97%
2020 94.990.000 28.95%
2021 88.209.000 -7.69%
2022 74.046.000 -19.13%
2023 67.782.000 -9.24%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Vital Limited Liabilities
Year Liabilities Growth
2004 17.003.000
2005 13.116.000 -29.64%
2006 10.173.000 -28.93%
2007 34.807.000 70.77%
2008 37.077.000 6.12%
2009 35.153.000 -5.47%
2010 33.641.000 -4.49%
2011 31.216.000 -7.77%
2012 29.882.000 -4.46%
2013 53.381.000 44.02%
2014 53.703.000 0.6%
2015 52.329.000 -2.63%
2016 50.415.000 -3.8%
2017 38.354.000 -31.45%
2018 34.369.000 -11.59%
2019 25.391.000 -35.36%
2020 53.250.000 52.32%
2021 46.426.000 -14.7%
2022 52.379.000 11.37%
2023 46.298.000 -13.13%

Vital Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
0x
Price To Sales Ratio
0.4x
POCF Ratio
0
PFCF Ratio
-3.6
Price to Book Ratio
0
EV to Sales
1.64
EV Over EBITDA
4.66
EV to Operating CashFlow
0
EV to FreeCashFlow
-14.79
Earnings Yield
0
FreeCashFlow Yield
-0.28
Market Cap
0,01 Bil.
Enterprise Value
0,05 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0
ROE
-0.01
Return On Assets
-0
Return On Capital Employed
0.08
Net Income per EBT
0.59
EBT Per Ebit
-0.05
Ebit per Revenue
0.09
Effective Tax Rate
0.37

Margins

Sales, General, & Administrative to Revenue
0.39
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.45
Operating Profit Margin
0.09
Pretax Profit Margin
-0
Net Profit Margin
-0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
-0.11
Capex to Depreciation
0
Return on Invested Capital
0.01
Return on Tangible Assets
-0
Days Sales Outstanding
38.74
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
9.42
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
1.64
Debt to Assets
0.52
Net Debt to EBITDA
3.52
Current Ratio
0.54
Tangible Asset Value
0,02 Bil.
Net Current Asset Value
-0,04 Bil.
Invested Capital
1.64
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
1324000
Debt to Market Cap
3.15

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Vital Limited Dividends
Year Dividends Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2019 0 0%
2020 0 0%
2021 0 0%

Vital Limited Profile

About Vital Limited

Vital Limited provides mobile radio networks and high-speed broadband services in New Zealand. The company operates in two segments, Wireless Networks and Wired Networks. It offers fiber and Ethernet solutions; and broadband connectivity and ancillary related services to a range of wholesale customers and end users. The company also provides data and GPS tracking products, as well as finance leasing services. It serves government, civil defense, emergency service, health, utility, public transport, education, logistics and freight, agriculture, and channel partner customers. The company was formerly known as TeamTalk Limited and changed its name to Vital Limited in July 2019. Vital Limited was incorporated in 1994 and is headquartered in Wellington, New Zealand.

CEO
Mr. Jason Bull
Employee
73
Address
Tower B
Wellington, 6011

Vital Limited Executives & BODs

Vital Limited Executives & BODs
# Name Age
1 Mr. Paul Kerr
Chief Financial Officer
70
2 Mr. Geoff Burt
Head of Sales & Customer Success
70
3 Mr. Jason Bull
Chief Executive Officer
70
4 Mr. Stuart MacIntyre
Chief Technology Officer
70
5 Mr. Mark Finnigan
Head of People & Safety
70
6 Mr. Marc Farrelly
Head of Field Force
70
7 Mr. Richard Hille
Head of Delivery
70

Vital Limited Competitors